Log in | Register

Search Results

Results 1 to 10 of 64 for "Therapeutic drug monitoring"

Restrict your results to one of the following articles types (number of results in parentheses):

Restrict your results to those published in the following timeframe (number of results in parentheses):

  1. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

    Jan J. De Waele, S. Carrette, M. Carlier, V. Stove, J. Boelens, G. Claeys, I. Leroux-Roels, E. Hoste, P. Depuydt, J. Decruyenaere, A. G. Verstraete
    Volume 40, Number 3 / March, 2014

  2. Clinical implications of antibiotic pharmacokinetic principles in the critically ill

    Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman
    Volume 39, Number 12 / December, 2013

  3. Dosing of medications in morbidly obese patients in the intensive care unit setting

    Brian L. Erstad
    Volume 30, Number 1 / January, 2004

  4. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections

    T. Tängdén, V. Ramos Martín, T. W. Felton, E. I. Nielsen, S. Marchand, R. J. Brüggemann, J. B. Bulitta, M. Bassetti, U. Theuretzbacher, B. T. Tsuji, D. W. Wareham, L. E. Friberg, J. J. De Waele, V. H. Tam, Jason A. Roberts
    Volume 43, Number 7 / July, 2017

  5. Understanding PK/PD

    Jason A. Roberts, Fabio Silvio Taccone, Jeffrey Lipman
    Volume 42, Number 11 / November, 2016
    Understanding the Disease

  6. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

    Andrew Rhodes, Laura E. Evans, Waleed Alhazzani, Mitchell M. Levy, Massimo Antonelli, Ricard Ferrer, Anand Kumar, Jonathan E. Sevransky, Charles L. Sprung, Mark E. Nunnally, Bram Rochwerg, Gordon D. Rubenfeld, Derek C. Angus, Djillali Annane, Richard J. Beale, Geoffrey J. Bellinghan, Gordon R. Bernard, Jean-Daniel Chiche, Craig Coopersmith, Daniel P. De Backer, Craig J. French, Seitaro Fujishima,
    Volume 43, Number 3 / March, 2017
    Conference Reports and Expert Panel

  7. Gain-of-function single nucleotide variants of the CYP2C19 gene (CYP2C19*17) can identify subtherapeutic voriconazole concentrations in critically ill patients: a case series

    Joachim D. Weigel, Nicole G. M. Hunfeld, Birgit C. P. Koch, Mohamud Egal, Jan Bakker, Ron H. N. van Schaik, Teun van Gelder
    Volume 41, Number 11 / November, 2015

  8. Levels of vancomycin in the cerebral interstitial fluid after severe head injury

    Anselmo Caricato, Mariano Pennisi, Aldo Mancino, Gianluca Vigna, Claudio Sandroni, Andrea Arcangeli, Massimo Antonelli
    Volume 32, Number 2 / February, 2006
    Brief Report

  9. What’s new in invasive pulmonary aspergillosis in the critically ill

    Despoina Koulenti, Dirk Vogelaers, Stijn Blot
    Volume 40, Number 5 / May, 2014
    What's New in Intensive Care

  10. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis

    Yuko Shimamoto, Tsuyoshi Fukuda, Kazuhiko Tanaka, Katsuya Komori, Daikai Sadamitsu
    Volume 39, Number 7 / July, 2013

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement